Orthocell Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.06 |
Market Cap |
AUD74.38 M |
Shares Outstanding |
152.97 M |
Public Float |
- |
Address |
Building 191 Murdoch Western Australia (WA) 6150 Australia |
Employees | - |
Website | http://www.orthocell.com.au |
Updated | 07/08/2019 |
Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. Its products include CelGro which derives collagen medical device for soft tissue repair; and Antologous Tenocyte Implantation (Ortho-ATI) for chronic, treatment resistant tendon injuries. The company was founded by Paul Anderson and Min Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia. |